NEW YORK, NY – February 5, 2024 – Edgemont Partners (“Edgemont”), a premier healthcare-dedicated investment bank and leading M&A and capital raising advisor, is pleased to announce that Igor Sokolovsky has joined the firm as a Managing Director to lead and expand its Diagnostics, Life Science Tools and Animal Health coverage efforts.

Mr. Sokolovsky joins Edgemont from Moelis, where he was a Managing Director and focused on M&A transactions in Healthcare and Animal Health. Prior to that, Mr. Sokolovsky worked at Guggenheim Securities where he focused on the Healthcare, Animal Health and Media & Information Services sectors. He previously held roles in Healthcare and M&A at Citigroup, J.P. Morgan, and Lehman Brothers. Before his career in investment banking, Mr. Sokolovsky served as a management consultant at Stern Stewart & Co. Mr. Sokolovsky received an MBA in Finance from the Wharton School at the University of Pennsylvania and a BS in Finance and Accounting from the Leonard N. Stern School of Business at New York University.

Mr. Sokolovsky will be based in Edgemont’s New York office, reporting to Co-Founders David Blume and Jeff Swearingen.

About Edgemont Partners
Founded in 2001, Edgemont ranks among the most active and best-performing independent healthcare M&A and financial advisors in the U.S. We focus solely on providing expert strategic advice and transaction execution to healthcare and life sciences companies, bringing a steadfast commitment to our clients, driven always to prioritize their best interests. Edgemont’s principals have executed 200+ transactions with an aggregate value of $90 billion+.

Investment banking services are provided by Edgemont Capital Partners, LP, a registered broker-dealer and member of FINRA and SIPC.